{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:52:11Z","timestamp":1792468331789,"version":"4.5.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00334","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T04:54:14Z","timestamp":1582692854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":195,"title":["Cross-Reactive Immunity Among Flaviviruses"],"prefix":"10.3389","volume":"11","author":[{"given":"Abhay P. S.","family":"Rathore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"St. John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"B1","first-page":"991","article-title":"Flaviviridae: the viruses and their replication.","author":"Lindenbach","year":"2001","journal-title":"Fields Virology."},{"key":"B2","article-title":"The Online 10th Report of the International Committee on Taxonomy of Viruses. Flaviviridae, Genus: Flavivirus.","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/vbz.2008.0216","article-title":"Flavivirus RNA in phlebotomine sandflies.","volume":"10","author":"Moureau","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"B4","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20072290","article-title":"Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine.","volume":"204","author":"Norrby","year":"2007","journal-title":"J Exp Med."},{"key":"B5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1099\/0022-1317-23-1-91","article-title":"The Flaviviruses (group B arboviruses): a cross-neutralization study.","volume":"23","author":"De Madrid","year":"1974","journal-title":"J Gen Virol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000149642","article-title":"Flaviviridae.","volume":"24","author":"Westaway","year":"1985","journal-title":"Intervirology."},{"key":"B7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.2164-0947.1957.tb00526.x","article-title":"Viruses: the versatile parasites; the arthropod-borne group of animal viruses.","volume":"19","author":"Casals","year":"1957","journal-title":"Trans N Y Acad Sci."},{"key":"B8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.99.5.429","article-title":"Hemagglutination with arthropod-borne viruses.","volume":"99","author":"Casals","year":"1954","journal-title":"J Exp Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between Flaviviruses as determined by cross-neutralization tests with polyclonal antisera.","author":"Calisher","year":"1989","journal-title":"J Gen Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections.","volume":"19","author":"St John","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","article-title":"Lack of durable cross-neutralizing antibodies against Zika virus from Dengue virus infection.","volume":"23","author":"Collins","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4269\/ajtmh.1970.19.110","article-title":"Immunologic studies with yellow fever and selected African group B arboviruses in rhesus and vervet monkeys.","volume":"19","author":"Henderson","year":"1970","journal-title":"Am J Trop Med Hyg."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aar4297","article-title":"Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells.","volume":"4","author":"Saron","year":"2018","journal-title":"Sci Adv."},{"key":"B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":". Immunization with heterologous Flaviviruses protective against fatal West Nile encephalitis.","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"B16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1348-0421.1994.tb02152.x","article-title":"Studies on serological cross-reaction in sequential Flavivirus infections.","volume":"38","author":"Makino","year":"1994","journal-title":"Microbiol Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","article-title":"Flavivirus-induced antibody cross-reactivity.","author":"Mansfield","year":"2011","journal-title":"J Gen Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcv.2017.05.001","article-title":"Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.","volume":"92","author":"van Meer","year":"2017","journal-title":"J Clin Virol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II.","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg."},{"key":"B20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0035-9203(59)90072-0","article-title":"Yellow fever and other arthropod-borne viruses; a consideration of two serological surveys made in South Western Nigeria.","volume":"53","author":"Macnamara","year":"1959","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2015.03.020","article-title":"Limited susceptibility of mice to Usutu virus (USUV) infection and induction of Flavivirus cross-protective immunity.","volume":"482","author":"Blazquez","year":"2015","journal-title":"Virology."},{"key":"B22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4269\/ajtmh.2001.65.379","article-title":"Experimental infections of pigs with Japanese encephalitis virus and closely related Australian Flaviviruses.","volume":"65","author":"Williams","year":"2001","journal-title":"Am J Trop Med Hyg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.celrep.2019.01.052","article-title":"Dengue and Zika virus cross-reactive human monoclonal antibodies protect against spondweni virus infection and pathogenesis in mice.","volume":"26","author":"Salazar","year":"2019","journal-title":"Cell Rep."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge.","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.","volume":"356","author":"Bardina","year":"2017","journal-title":"Science."},{"key":"B26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue virus immunity increases Zika virus-induced damage during pregnancy.","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav3208","article-title":"Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses.","volume":"5","author":"Rathore","year":"2019","journal-title":"Sci Adv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ebiom.2019.05.014","article-title":"In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy.","volume":"44","author":"Camargos","year":"2019","journal-title":"EBioMedicine."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02260","article-title":"Seeking Flavivirus cross-protective immunity.","volume":"10","author":"Dos Santos Franco","year":"2019","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.immuni.2006.05.015","article-title":"Altered peptide ligands induce delayed CD8-T cell receptor interaction\u2013a role for CD8 in distinguishing antigen quality.","volume":"25","author":"Yachi","year":"2006","journal-title":"Immunity."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02631","article-title":"Heterologous immunity: role in natural and vaccine-induced resistance to infections.","volume":"10","author":"Agrawal","year":"2019","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1099\/0022-1317-68-10-2655","article-title":"Flavivirus-specific murine L3T4+ T cell clones: induction, characterization and cross-reactivity.","author":"Uren","year":"1987","journal-title":"J Gen Virol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/0022-1317-73-5-1115","article-title":"Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to Flaviviruses.","author":"Hill","year":"1992","journal-title":"J Gen Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/jvi.73.1.398-403.1999","article-title":"Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: Flavivirus cross-reactivity and influence of infecting serotype.","volume":"73","author":"Spaulding","year":"1999","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01469-17","article-title":"Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans.","volume":"91","author":"Grifoni","year":"2017","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/653486","article-title":"Sequential immunization with heterologous chimeric Flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.","volume":"202","author":"Singh","year":"2010","journal-title":"J Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.4049\/jimmunol.1801090","article-title":"Cutting edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of Zika virus-specific CD8(+) T cells.","volume":"201","author":"Grifoni","year":"2018","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01424","article-title":"A modified mRNA vaccine targeting immunodominant NS epitopes protects against Dengue virus infection in HLA Class I transgenic mice.","volume":"10","author":"Roth","year":"2019","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ni.3850","article-title":"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8(+) T cell response.","volume":"18","author":"Culshaw","year":"2017","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/eji.200737699","article-title":"Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.","volume":"38","author":"Moran","year":"2008","journal-title":"Eur J Immunol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"8032","DOI":"10.1128\/JVI.72.10.8032-8036.1998","article-title":"Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: Flavivirus cross-reactivity, protein recognition, and cytotoxic activity.","volume":"72","author":"Aihara","year":"1998","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.170.3.763","article-title":"Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.","volume":"170","author":"Kurane","year":"1989","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7828","DOI":"10.1128\/JVI.00196-14","article-title":"Specificities of human CD4+ T cell responses to an inactivated Flavivirus vaccine and infection: correlation with structure and epitope prediction.","volume":"88","author":"Schwaiger","year":"2014","journal-title":"J Virol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09331-w","article-title":"Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination.","volume":"7","author":"Koblischke","year":"2017","journal-title":"Sci Rep."},{"key":"B47","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/JVI.22.3.608-618.1977","article-title":"Antigenic characterization of Flavivirus structural proteins separated by isoelectric focusing.","volume":"22","author":"Trent","year":"1977","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of Flavivirus envelope glycoprotein cross-reactive epitopes.","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant Flavivirus cross-reactive antigenic sites.","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to Flaviviruses: lessons for vaccine design.","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes.","volume":"4","author":"Collins","year":"2019","journal-title":"JCI Insight."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12677-6","article-title":"Oligomeric state of the ZIKV E protein defines protective immune responses.","volume":"10","author":"Metz","year":"2019","journal-title":"Nat Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization.","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","article-title":"Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.","volume":"18","author":"Fernandez","year":"2017","journal-title":"Nat Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans.","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016059","article-title":"A broadly Flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.","volume":"6","author":"Deng","year":"2011","journal-title":"PLoS One."},{"key":"B58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe."},{"key":"B59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.virol.2004.06.052","article-title":"Genetic characterization of yokose virus, a Flavivirus isolated from the bat in Japan.","volume":"332","author":"Tajima","year":"2005","journal-title":"Virology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue.","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature."},{"key":"B61","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus.","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05291","article-title":"Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcgamma receptors.","volume":"4","author":"Syenina","year":"2015","journal-title":"Elife."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003783","article-title":"Influence of mast cells on dengue protective immunity and immune pathology.","volume":"9","author":"St John","year":"2013","journal-title":"PLoS Pathog."},{"key":"B64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/JVI.52.1.223-230.1984","article-title":"Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.","volume":"52","author":"Kurane","year":"1984","journal-title":"J Virol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus.","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.","volume":"1","author":"Chan","year":"2016","journal-title":"Nat Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/jvi.72.1.73-83.1998","article-title":"Phylogeny of the genus Flavivirus.","volume":"72","author":"Kuno","year":"1998","journal-title":"J Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1084\/jem.20191061","article-title":"Risk of Zika microcephaly correlates with features of maternal antibodies.","volume":"216","author":"Robbiani","year":"2019","journal-title":"J Exp Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region.","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.","volume":"4","author":"Bradt","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B71","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3201\/eid2210.160818","article-title":"Resurgence of yellow fever in Angola, 2015-2016.","volume":"22","author":"Grobbelaar","year":"2016","journal-title":"Emerg Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/cid\/ciy777","article-title":"What\u2019s old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.","volume":"68","author":"Chen","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine."},{"key":"B75","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am J Trop Med Hyg."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cmi.2018.01.018","article-title":"Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America.","volume":"24","author":"Arredondo-Garcia","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5710","article-title":"Is Dengvaxia a useful vaccine for dengue endemic areas?","volume":"367","author":"Gubler","year":"2019","journal-title":"BMJ."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00705-016-2817-8","article-title":"A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.","volume":"161","author":"Yang","year":"2016","journal-title":"Arch Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1016\/j.vaccine.2011.07.020","article-title":"Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.","volume":"29","author":"Osorio","year":"2011","journal-title":"Vaccine."},{"key":"B81","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","article-title":"Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.","volume":"18","author":"Saez-Llorens","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent Dengue vaccine in healthy children and adolescents.","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med."},{"key":"B83","first-page":"223","article-title":"The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance.","volume":"267","author":"Roehrig","year":"2002","journal-title":"Curr Top Microbiol Immunol."},{"key":"B84","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3201\/eid2006.140138","article-title":"Zika virus, French polynesia, South pacific, 2013.","volume":"20","author":"Cao-Lormeau","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"B85","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4269\/ajtmh.1994.50.570","article-title":"First isolations of arboviruses from phlebotomine sand flies in West Africa.","volume":"50","author":"Fontenille","year":"1994","journal-title":"Am J Trop Med Hyg."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets.","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol."},{"key":"B87","first-page":"275","article-title":"The rapid generation of mutation data matrices from protein sequences.","volume":"8","author":"Jones","year":"1992","journal-title":"Comput Appl Biosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1558-5646.1985.tb00420.x","article-title":"Confidence limits on phylogenies: an approach using the bootstrap.","volume":"39","author":"Felsenstein","year":"1985","journal-title":"Evolution."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T04:54:20Z","timestamp":1582692860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2020.00334"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00334","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"article-number":"334"}}